Advanced age does not exclude lobectomy for non-small cell lung carcinoma

Area of Science:

• Thoracic Surgery
• Oncology
• Geriatric Medicine

Background:

• Complete surgical resection, often lobectomy, is the standard treatment for localized non-small cell lung cancer (NSCLC).
• The impact of lobectomy on the health status of elderly patients (>= 70 years) remains incompletely understood.
• Assessing pulmonary function and functional status post-lobectomy is crucial for elderly NSCLC patients.

Purpose of the Study:

• To compare the effects of lobectomy on pulmonary function and functional status in elderly (>= 70 years) versus younger (< 70 years) patients with NSCLC.
• To evaluate long-term outcomes (1 year post-surgery) following lobectomy in different age groups.
• To inform treatment decisions regarding age as a sole contraindication for curative NSCLC resection.

Main Methods:

• A cohort of 140 patients with NSCLC undergoing lobectomy was studied.
• Pulmonary function tests (PFTs) and Karnofsky scores (KS) were assessed preoperatively and 1 year postoperatively in 63 patients.
• Comparison of PFTs and KS between elderly (>= 70) and younger (< 70) patient groups.

Main Results:

• No significant differences in pulmonary function (FVC, FEV1) or functional status (KS) were observed between elderly and younger patients at 1 year post-lobectomy.
• While both groups experienced declines in FVC and FEV1, the percentage decrease was comparable.
• A higher percentage of younger patients experienced a decline in functional status (KS) compared to elderly patients.

Conclusions:

• Elderly patients (>= 70 years) undergoing lobectomy for NSCLC experience comparable pulmonary and functional outcomes to younger patients one year after surgery.
• Age should not be a limiting factor in offering curative surgical treatment for NSCLC.
• Lobectomy is a viable option for elderly patients with NSCLC, with outcomes similar to younger counterparts.